Zobrazeno 81 - 90
of 136
pro vyhledávání: '"Michael Mian"'
Publikováno v:
Pneumologie. 67
Autor:
Massimo Federico, Andrea Rossi, Sergio Cortelazzo, Emanuele Zucca, Henry L. Gomez, Armando López-Guillermo, Maria Elena Cabrera, F. Cavalli, R Tsang, Gianluca Gaidano, Michael Mian, Maurizio Martelli
Publikováno v:
Pneumologie. 67
Autor:
Ines Wasle, Michael Studnicka, Wolfgang Hilbe, R Pirker, Michael Fiegl, Andreas Pircher, E Ulsperger, K Wilthoner, Michael Mian
Publikováno v:
Pneumologie. 67
Autor:
H Jamnig, Georg Pall, Michael Mian, Thomas Schmid, W Oberaigner, Michael Fiegl, M Nevinny, Ines Wasle, Wolfgang Hilbe
Publikováno v:
Pneumologie. 67
Autor:
Maria Elena Cabrera, Michael Mian, Daniela Capello, C. Visco, Elena Oldani, Richard W. Tsang, A. Rossi, Gonzalo Gutiérrez-García, Mirija Svaldi, Maurizio Martelli, D. Grazio, Alessandro Rambaldi, Luigi Marcheselli, Stefano Luminari, Emanuele Zucca, Michael Fiegl, Gianluca Gaidano, M. B. Ventre, Mary Gospodarowicz, Enrico Pogliani, Sergio Cortelazzo, Fausto Rossini, Massimo Federico, F. Cavalli, Davide Rossi, Mario Busetto
Publikováno v:
Annals of hematology. 93(2)
It is known that extranodal head and neck diffuse large B cell lymphomas (eHN-DLBCL) can affect various anatomical structures what is not well-known, however, is whether they differ in terms of clinical presentation and outcome. Clinical data of the
Autor:
Eberhard Gunsilius, Wolfgang Willenbacher, Michael Fiegl, Ines Wasle, Sergio Cortelazzo, Wolfgang Prokop, Andrea Griesmacher, Manfred Herold, Michael Mian, Irene Franz, Günther Gastl
Publikováno v:
Annals of hematology. 92(9)
Idiopathic Bence-Jones proteinuria (BJP) is a rare plasma cell dyscrasia, of which the clinical and biological characteristics are yet unclear. Historical data suggested that they are at higher risk of progression to multiple myeloma or other related
Autor:
Simona Puglisi, Rossella Paolini, Michael Mian, Renato Fanin, Francesco Rodeghiero, Giovanni Pizzolo, Monica Castelli, Sergio Cortelazzo, Ilaria Nichele, Gianpietro Semenzato, Paolo Vivaldi, Livio Trentin, Miriam Isola, Rosaria Sancetta, Stefano Volpetti, Achille Ambrosetti, Francesco Zaja, Carlo Visco, Cinzia Sissa
Bendamustine proved to be effective for the treatment of chronic lymphocytic leukemia (CLL). However, the relationship between its activity with clinico-biological prognosticators has been addressed only in few studies. We retrospectively evaluated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e267c9ca584d4f3fa75d6e84956eb5
http://hdl.handle.net/11562/993290
http://hdl.handle.net/11562/993290
Autor:
Mario Uhr, Afua Adjeiwaa Mensah, Francesco Forconi, Gianluca Gaidano, Marco Ladetto, Emanuele Zucca, Georg Stussi, Michael Mian, Ivo Kwee, Roberto Marasca, F. Cavalli, Davide Rossi, Andrea Rinaldi, Francesco Bertoni
Background: Genomic complexity can predict the clinical course of patients affected by chronic lymphocytic leukemia (CLL) with a normal FISH. However, large studies are still lacking. Here, we analyzed a large series of CLL patients and also carried
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704d149e0530a3109c334a12420f234a
http://hdl.handle.net/2318/1615015
http://hdl.handle.net/2318/1615015
Autor:
Jiří Mayer, Richard Greil, Reinhard Stauder, Michael Mian, August Zabernigg, Michael Fiegl, Georg Hopfinger, Michael Steurer, Cathrin Skrabs, F. Schmid, Alois Lang, Alois Walder, F. Haslbaur, G. Winder, Guenther Gastl, Daniela Voskova, Yvona Brychtová
Publikováno v:
Annals of hematology. 93(2)
This retrospective study evaluated the benefit of alemtuzumab monotherapy in unselected patients with advanced B-cell chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (B-PLL) to definitely describe the impact of this antibody in clinica